Suzuki M, Ohyama Y, Satoh S
J Cardiovasc Pharmacol. 1984 Mar-Apr;6(2):244-50. doi: 10.1097/00005344-198403000-00006.
We studied the effects of angiotensin I (AI), angiotensin II (AII), and bradykinin (BK) on systemic blood pressure and blood flow in the renal, mesenteric, coeliac, external iliac, and internal iliac vascular beds in the presence and absence of the converting enzyme inhibitor captopril in pentobarbital-anesthetized dogs. AI and AII caused dose-dependent pressor responses and blood flow reductions, and BK caused dose-related depressor responses and an increase in blood flow. The pressor response to AI was decreased and the depressor response to BK was potentiated by captopril. However, the effectiveness of captopril was greater when the peptides were injected intravenously than when they were injected intraaortically. The average conversion of AI to AII in the mesenteric, coeliac, external iliac, internal iliac, and renal vascular beds was 45.7, 31.6, 30.6, 28.0, and 8.9%, respectively. The dose ratio of equipotent BK-induced responses before and after captopril in the mesenteric, coeliac, external iliac, internal iliac, and renal vascular beds was 4.6, 3.5, 2.8, 2.5 and 1.4, respectively. This order was similar to that of the percentage conversion of AI to AII. These results suggest that the greatest proportion of angiotensin conversion and BK inactivation occurs in the pulmonary circulation and that the least proportion occurs in the kidney.
我们研究了在戊巴比妥麻醉的犬中,血管紧张素I(AI)、血管紧张素II(AII)和缓激肽(BK)在存在和不存在转化酶抑制剂卡托普利的情况下,对全身血压以及肾、肠系膜、腹腔、髂外和髂内血管床血流量的影响。AI和AII引起剂量依赖性升压反应和血流量减少,而BK引起剂量相关性降压反应和血流量增加。卡托普利可降低对AI的升压反应,并增强对BK的降压反应。然而,当肽经静脉注射时,卡托普利的效果比经主动脉注射时更好。在肠系膜、腹腔、髂外、髂内和肾血管床中,AI向AII的平均转化率分别为45.7%、31.6%、30.6%、28.0%和8.9%。在肠系膜、腹腔、髂外、髂内和肾血管床中,卡托普利给药前后等效BK诱导反应的剂量比分别为4.6、3.5、2.8、2.5和1.4。这个顺序与AI向AII的转化率百分比顺序相似。这些结果表明,血管紧张素转化和BK失活的最大比例发生在肺循环中,而最小比例发生在肾脏中。